Repression of SV40 T oncoprotein expression by DMSO

Area of Science:

• Oncology
• Cell Biology
• Molecular Biology

Background:

• Murine mesenchymal 3T3 T stem cells (CSV3 cells) transformed by SV40 large T oncoprotein can differentiate into adipocytes, with concomitant repression of T oncoprotein expression.
• Investigating pharmacological induction of T oncoprotein repression is crucial to understand mechanisms independent of differentiation.

Purpose of the Study:

• To determine if T oncoprotein expression can be pharmacologically repressed in CSV3 cells.
• To establish if repression mechanisms are independent of overt cell differentiation.
• To explore the potential of pharmacological repression as a cancer suppressor activity.

Main Methods:

• CSV3 cells were treated with various agents known to induce differentiation in other cell types.
• Dimethyl sulfoxide (DMSO) was identified as the sole agent repressing T oncoprotein expression.
• Posttranslational mechanisms affecting T oncoprotein stability and cell phenotype reversion were analyzed.

Main Results:

• DMSO repressed SV40 T oncoprotein expression in a dosage- and time-dependent manner (24-96 hours).
• Repression was mediated by posttranslational mechanisms reducing T oncoprotein stability.
• DMSO treatment led to reversion of the transformed CSV3 cell phenotype, including loss of mitogen responsiveness.

Conclusions:

• Pharmacological repression of SV40 T oncoprotein expression by DMSO is achievable in CSV3 cells.
• This repression occurs via mechanisms distinct from cell differentiation.
• The findings support the concept of pharmacological repression of T oncoprotein as a distinct cancer suppressor mechanism.